Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Sorafenib Sales Market Report 2016

  • QYR670245
  • 122 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Sorafenib

Revenue, means the sales value of Sorafenib

This report studies sales (consumption) of Sorafenib in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

Pfizer

Allergan

Alnylam Pharmaceuticals

Amgen

Angstrom Pharmaceuticals

Acceleron Pharma

Biocon

Bionomics

CASI Pharmaceuticals

Celgene Corporation

Enzon Pharmaceuticals

Five Prime Therapeutics

Fujifilm Kyowa Kirin Biologics

Genentech

Genexine

Hetero Drugs

ImClone Systems

Intas Pharmaceuticals

Kyowa Hakko Kirin

Levolta Pharmaceuticals

Mabtech

Marsala Biotech

Neumedicines

Novartis

Oncobiologics

Onyx Pharmaceuticals

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Sorafenib in these regions, from 2011 to 2021 (forecast), like

USA

China

Europe

Japan

India

Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Sorafenib in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

Global Sorafenib Sales Market Report 2016

1 Sorafenib Overview

1.1 Product Overview and Scope of Sorafenib

1.2 Classification of Sorafenib

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Sorafenib

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Sorafenib Market by Regions

1.4.1 USA Status and Prospect (2011-2021)

1.4.2 China Status and Prospect (2011-2021)

1.4.3 Europe Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 India Status and Prospect (2011-2021)

1.4.6 Southeast Asia Status and Prospect (2011-2021)

1.5 Global Market Size (Value and Volume) of Sorafenib (2011-2021)

1.5.1 Global Sorafenib Sales and Growth Rate (2011-2021)

1.5.2 Global Sorafenib Revenue and Growth Rate (2011-2021)

2 Global Sorafenib Competition by Manufacturers, Type and Application

2.1 Global Sorafenib Market Competition by Manufacturers

2.1.1 Global Sorafenib Sales and Market Share of Key Manufacturers (2011-2016)

2.1.2 Global Sorafenib Revenue and Share by Manufacturers (2011-2016)

2.2 Global Sorafenib (Volume and Value) by Type

2.2.1 Global Sorafenib Sales and Market Share by Type (2011-2016)

2.2.2 Global Sorafenib Revenue and Market Share by Type (2011-2016)

2.3 Global Sorafenib (Volume and Value) by Regions

2.3.1 Global Sorafenib Sales and Market Share by Regions (2011-2016)

2.3.2 Global Sorafenib Revenue and Market Share by Regions (2011-2016)

2.4 Global Sorafenib (Volume) by Application

3 USA Sorafenib (Volume, Value and Sales Price)

3.1 USA Sorafenib Sales and Value (2011-2016)

3.1.1 USA Sorafenib Sales and Growth Rate (2011-2016)

3.1.2 USA Sorafenib Revenue and Growth Rate (2011-2016)

3.1.3 USA Sorafenib Sales Price Trend (2011-2016)

3.2 USA Sorafenib Sales and Market Share by Manufacturers

3.3 USA Sorafenib Sales and Market Share by Type

3.4 USA Sorafenib Sales and Market Share by Application

4 China Sorafenib (Volume, Value and Sales Price)

4.1 China Sorafenib Sales and Value (2011-2016)

4.1.1 China Sorafenib Sales and Growth Rate (2011-2016)

4.1.2 China Sorafenib Revenue and Growth Rate (2011-2016)

4.1.3 China Sorafenib Sales Price Trend (2011-2016)

4.2 China Sorafenib Sales and Market Share by Manufacturers

4.3 China Sorafenib Sales and Market Share by Type

4.4 China Sorafenib Sales and Market Share by Application

5 Europe Sorafenib (Volume, Value and Sales Price)

5.1 Europe Sorafenib Sales and Value (2011-2016)

5.1.1 Europe Sorafenib Sales and Growth Rate (2011-2016)

5.1.2 Europe Sorafenib Revenue and Growth Rate (2011-2016)

5.1.3 Europe Sorafenib Sales Price Trend (2011-2016)

5.2 Europe Sorafenib Sales and Market Share by Manufacturers

5.3 Europe Sorafenib Sales and Market Share by Type

5.4 Europe Sorafenib Sales and Market Share by Application

6 Japan Sorafenib (Volume, Value and Sales Price)

6.1 Japan Sorafenib Sales and Value (2011-2016)

6.1.1 Japan Sorafenib Sales and Growth Rate (2011-2016)

6.1.2 Japan Sorafenib Revenue and Growth Rate (2011-2016)

6.1.3 Japan Sorafenib Sales Price Trend (2011-2016)

6.2 Japan Sorafenib Sales and Market Share by Manufacturers

6.3 Japan Sorafenib Sales and Market Share by Type

6.4 Japan Sorafenib Sales and Market Share by Application

7 India Sorafenib (Volume, Value and Sales Price)

7.1 India Sorafenib Sales and Value (2011-2016)

7.1.1 India Sorafenib Sales and Growth Rate (2011-2016)

7.1.2 India Sorafenib Revenue and Growth Rate (2011-2016)

7.1.3 India Sorafenib Sales Price Trend (2011-2016)

7.2 India Sorafenib Sales and Market Share by Manufacturers

7.3 India Sorafenib Sales and Market Share by Type

7.4 India Sorafenib Sales and Market Share by Application

8 Southeast Asia Sorafenib (Volume, Value and Sales Price)

8.1 Southeast Asia Sorafenib Sales and Value (2011-2016)

8.1.1 Southeast Asia Sorafenib Sales and Growth Rate (2011-2016)

8.1.2 Southeast Asia Sorafenib Revenue and Growth Rate (2011-2016)

8.1.3 Southeast Asia Sorafenib Sales Price Trend (2011-2016)

8.2 Southeast Asia Sorafenib Sales and Market Share by Manufacturers

8.3 Southeast Asia Sorafenib Sales and Market Share by Type

8.4 Southeast Asia Sorafenib Sales and Market Share by Application

9 Global Sorafenib Manufacturers Analysis

9.1 Pfizer

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 Sorafenib Product Type, Application and Specification

9.1.2.1 Type I

9.1.2.2 Type II

9.1.3 Pfizer Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

9.1.4 Main Business/Business Overview

9.2 Allergan

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 122 Product Type, Application and Specification

9.2.2.1 Type I

9.2.2.2 Type II

9.2.3 Allergan Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

9.2.4 Main Business/Business Overview

9.3 Alnylam Pharmaceuticals

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 145 Product Type, Application and Specification

9.3.2.1 Type I

9.3.2.2 Type II

9.3.3 Alnylam Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

9.3.4 Main Business/Business Overview

9.4 Amgen

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 Aug Product Type, Application and Specification

9.4.2.1 Type I

9.4.2.2 Type II

9.4.3 Amgen Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

9.4.4 Main Business/Business Overview

9.5 Angstrom Pharmaceuticals

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 Product Type, Application and Specification

9.5.2.1 Type I

9.5.2.2 Type II

9.5.3 Angstrom Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

9.5.4 Main Business/Business Overview

9.6 Acceleron Pharma

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 Million USD Product Type, Application and Specification

9.6.2.1 Type I

9.6.2.2 Type II

9.6.3 Acceleron Pharma Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

9.6.4 Main Business/Business Overview

9.7 Biocon

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 Pharma & Healthcare Product Type, Application and Specification

9.7.2.1 Type I

9.7.2.2 Type II

9.7.3 Biocon Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

9.7.4 Main Business/Business Overview

9.8 Bionomics

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 Product Type, Application and Specification

9.8.2.1 Type I

9.8.2.2 Type II

9.8.3 Bionomics Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

9.8.4 Main Business/Business Overview

9.9 CASI Pharmaceuticals

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 Product Type, Application and Specification

9.9.2.1 Type I

9.9.2.2 Type II

9.9.3 CASI Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

9.9.4 Main Business/Business Overview

9.10 Celgene Corporation

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 Product Type, Application and Specification

9.10.2.1 Type I

9.10.2.2 Type II

9.10.3 Celgene Corporation Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

9.10.4 Main Business/Business Overview

9.11 Enzon Pharmaceuticals

9.12 Five Prime Therapeutics

9.13 Fujifilm Kyowa Kirin Biologics

9.14 Genentech

9.15 Genexine

9.16 Hetero Drugs

9.17 ImClone Systems

9.18 Intas Pharmaceuticals

9.19 Kyowa Hakko Kirin

9.20 Levolta Pharmaceuticals

9.21 Mabtech

9.22 Marsala Biotech

9.23 Neumedicines

9.24 Novartis

9.25 Oncobiologics

9.26 Onyx Pharmaceuticals

10 Sorafenib Maufacturing Cost Analysis

10.1 Sorafenib Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of Sorafenib

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 Sorafenib Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of Sorafenib Major Manufacturers in 2015

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global Sorafenib Market Forecast (2016-2021)

14.1 Global Sorafenib Sales, Revenue Forecast (2016-2021)

14.2 Global Sorafenib Sales Forecast by Regions (2016-2021)

14.3 Global Sorafenib Sales Forecast by Type (2016-2021)

14.4 Global Sorafenib Sales Forecast by Application (2016-2021)

15 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

List of Tables and Figures

Figure Picture of Sorafenib

Table Classification of Sorafenib

Figure Global Sales Market Share of Sorafenib by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Applications of Sorafenib

Figure Global Sales Market Share of Sorafenib by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure USA Sorafenib Revenue and Growth Rate (2011-2021)

Figure China Sorafenib Revenue and Growth Rate (2011-2021)

Figure Europe Sorafenib Revenue and Growth Rate (2011-2021)

Figure Japan Sorafenib Revenue and Growth Rate (2011-2021)

Figure India Sorafenib Revenue and Growth Rate (2011-2021)

Figure Southeast Asia Sorafenib Revenue and Growth Rate (2011-2021)

Figure Global Sorafenib Sales and Growth Rate (2011-2021)

Figure Global Sorafenib Revenue and Growth Rate (2011-2021)

Table Global Sorafenib Sales of Key Manufacturers (2011-2016)

Table Global Sorafenib Sales Share by Manufacturers (2011-2016)

Figure 2015 Sorafenib Sales Share by Manufacturers

Figure 2016 Sorafenib Sales Share by Manufacturers

Table Global Sorafenib Revenue by Manufacturers (2011-2016)

Table Global Sorafenib Revenue Share by Manufacturers (2011-2016)

Table 2015 Global Sorafenib Revenue Share by Manufacturers

Table 2016 Global Sorafenib Revenue Share by Manufacturers

Table Global Sorafenib Sales and Market Share by Type (2011-2016)

Table Global Sorafenib Sales Share by Type (2011-2016)

Figure Sales Market Share of Sorafenib by Type (2011-2016)

Figure Global Sorafenib Sales Growth Rate by Type (2011-2016)

Table Global Sorafenib Revenue and Market Share by Type (2011-2016)

Table Global Sorafenib Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Sorafenib by Type (2011-2016)

Figure Global Sorafenib Revenue Growth Rate by Type (2011-2016)

Table Global Sorafenib Sales and Market Share by Regions (2011-2016)

Table Global Sorafenib Sales Share by Regions (2011-2016)

Figure Sales Market Share of Sorafenib by Regions (2011-2016)

Figure Global Sorafenib Sales Growth Rate by Regions (2011-2016)

Table Global Sorafenib Revenue and Market Share by Regions (2011-2016)

Table Global Sorafenib Revenue Share by Regions (2011-2016)

Figure Revenue Market Share of Sorafenib by Regions (2011-2016)

Figure Global Sorafenib Revenue Growth Rate by Regions (2011-2016)

Table Global Sorafenib Sales and Market Share by Application (2011-2016)

Table Global Sorafenib Sales Share by Application (2011-2016)

Figure Sales Market Share of Sorafenib by Application (2011-2016)

Figure Global Sorafenib Sales Growth Rate by Application (2011-2016)

Figure USA Sorafenib Sales and Growth Rate (2011-2016)

Figure USA Sorafenib Revenue and Growth Rate (2011-2016)

Figure USA Sorafenib Sales Price Trend (2011-2016)

Table USA Sorafenib Sales by Manufacturers (2011-2016)

Table USA Sorafenib Market Share by Manufacturers (2011-2016)

Table USA Sorafenib Sales by Type (2011-2016)

Table USA Sorafenib Market Share by Type (2011-2016)

Table USA Sorafenib Sales by Application (2011-2016)

Table USA Sorafenib Market Share by Application (2011-2016)

Figure China Sorafenib Sales and Growth Rate (2011-2016)

Figure China Sorafenib Revenue and Growth Rate (2011-2016)

Figure China Sorafenib Sales Price Trend (2011-2016)

Table China Sorafenib Sales by Manufacturers (2011-2016)

Table China Sorafenib Market Share by Manufacturers (2011-2016)

Table China Sorafenib Sales by Type (2011-2016)

Table China Sorafenib Market Share by Type (2011-2016)

Table China Sorafenib Sales by Application (2011-2016)

Table China Sorafenib Market Share by Application (2011-2016)

Figure Europe Sorafenib Sales and Growth Rate (2011-2016)

Figure Europe Sorafenib Revenue and Growth Rate (2011-2016)

Figure Europe Sorafenib Sales Price Trend (2011-2016)

Table Europe Sorafenib Sales by Manufacturers (2011-2016)

Table Europe Sorafenib Market Share by Manufacturers (2011-2016)

Table Europe Sorafenib Sales by Type (2011-2016)

Table Europe Sorafenib Market Share by Type (2011-2016)

Table Europe Sorafenib Sales by Application (2011-2016)

Table Europe Sorafenib Market Share by Application (2011-2016)

Figure Japan Sorafenib Sales and Growth Rate (2011-2016)

Figure Japan Sorafenib Revenue and Growth Rate (2011-2016)

Figure Japan Sorafenib Sales Price Trend (2011-2016)

Table Japan Sorafenib Sales by Manufacturers (2011-2016)

Table Japan Sorafenib Market Share by Manufacturers (2011-2016)

Table Japan Sorafenib Sales by Type (2011-2016)

Table Japan Sorafenib Market Share by Type (2011-2016)

Table Japan Sorafenib Sales by Application (2011-2016)

Table Japan Sorafenib Market Share by Application (2011-2016)

Figure India Sorafenib Sales and Growth Rate (2011-2016)

Figure India Sorafenib Revenue and Growth Rate (2011-2016)

Figure India Sorafenib Sales Price Trend (2011-2016)

Table India Sorafenib Sales by Manufacturers (2011-2016)

Table India Sorafenib Market Share by Manufacturers (2011-2016)

Table India Sorafenib Sales by Type (2011-2016)

Table India Sorafenib Market Share by Type (2011-2016)

Table India Sorafenib Sales by Application (2011-2016)

Table India Sorafenib Market Share by Application (2011-2016)

Figure Southeast Asia Sorafenib Sales and Growth Rate (2011-2016)

Figure Southeast Asia Sorafenib Revenue and Growth Rate (2011-2016)

Figure Southeast Asia Sorafenib Sales Price Trend (2011-2016)

Table Southeast Asia Sorafenib Sales by Manufacturers (2011-2016)

Table Southeast Asia Sorafenib Market Share by Manufacturers (2011-2016)

Table Southeast Asia Sorafenib Sales by Type (2011-2016)

Table Southeast Asia Sorafenib Market Share by Type (2011-2016)

Table Southeast Asia Sorafenib Sales by Application (2011-2016)

Table Southeast Asia Sorafenib Market Share by Application (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Sorafenib Global Market Share (2011-2016)

Table Allergan Basic Information List

Table Allergan Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Allergan Sorafenib Global Market Share (2011-2016)

Table Alnylam Pharmaceuticals Basic Information List

Table Alnylam Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Alnylam Pharmaceuticals Sorafenib Global Market Share (2011-2016)

Table Amgen Basic Information List

Table Amgen Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Amgen Sorafenib Global Market Share (2011-2016)

Table Angstrom Pharmaceuticals Basic Information List

Table Angstrom Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Angstrom Pharmaceuticals Sorafenib Global Market Share (2011-2016)

Table Acceleron Pharma Basic Information List

Table Acceleron Pharma Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Acceleron Pharma Sorafenib Global Market Share (2011-2016)

Table Biocon Basic Information List

Table Biocon Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Biocon Sorafenib Global Market Share (2011-2016)

Table Bionomics Basic Information List

Table Bionomics Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Bionomics Sorafenib Global Market Share (2011-2016)

Table CASI Pharmaceuticals Basic Information List

Table CASI Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure CASI Pharmaceuticals Sorafenib Global Market Share (2011-2016)

Table Celgene Corporation Basic Information List

Table Celgene Corporation Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Celgene Corporation Sorafenib Global Market Share (2011-2016)

Table Enzon Pharmaceuticals Basic Information List

Table Enzon Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Enzon Pharmaceuticals Sorafenib Global Market Share (2011-2016)

Table Five Prime Therapeutics Basic Information List

Table Five Prime Therapeutics Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Five Prime Therapeutics Sorafenib Global Market Share (2011-2016)

Table Fujifilm Kyowa Kirin Biologics Basic Information List

Table Fujifilm Kyowa Kirin Biologics Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Fujifilm Kyowa Kirin Biologics Sorafenib Global Market Share (2011-2016)

Table Genentech Basic Information List

Table Genentech Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Genentech Sorafenib Global Market Share (2011-2016)

Table Genexine Basic Information List

Table Genexine Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Genexine Sorafenib Global Market Share (2011-2016)

Table Hetero Drugs Basic Information List

Table Hetero Drugs Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Hetero Drugs Sorafenib Global Market Share (2011-2016)

Table ImClone Systems Basic Information List

Table ImClone Systems Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure ImClone Systems Sorafenib Global Market Share (2011-2016)

Table Intas Pharmaceuticals Basic Information List

Table Intas Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Intas Pharmaceuticals Sorafenib Global Market Share (2011-2016)

Table Kyowa Hakko Kirin Basic Information List

Table Kyowa Hakko Kirin Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Kyowa Hakko Kirin Sorafenib Global Market Share (2011-2016)

Table Levolta Pharmaceuticals Basic Information List

Table Levolta Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Levolta Pharmaceuticals Sorafenib Global Market Share (2011-2016)

Table Mabtech Basic Information List

Table Mabtech Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Mabtech Sorafenib Global Market Share (2011-2016)

Table Marsala Biotech Basic Information List

Table Marsala Biotech Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Marsala Biotech Sorafenib Global Market Share (2011-2016)

Table Neumedicines Basic Information List

Table Neumedicines Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Neumedicines Sorafenib Global Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis Sorafenib Global Market Share (2011-2016)

Table Oncobiologics Basic Information List

Table Oncobiologics Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Oncobiologics Sorafenib Global Market Share (2011-2016)

Table Onyx Pharmaceuticals Basic Information List

Table Onyx Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Onyx Pharmaceuticals Sorafenib Global Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Sorafenib

Figure Manufacturing Process Analysis of Sorafenib

Figure Sorafenib Industrial Chain Analysis

Table Raw Materials Sources of Sorafenib Major Manufacturers in 2015

Table Major Buyers of Sorafenib

Table Distributors/Traders List

Figure Global Sorafenib Sales and Growth Rate Forecast (2016-2021)

Figure Global Sorafenib Revenue and Growth Rate Forecast (2016-2021)

Table Global Sorafenib Sales Forecast by Regions (2016-2021)

Table Global Sorafenib Sales Forecast by Type (2016-2021)

Table Global Sorafenib Sales Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370